GWAS |
- Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction) ( 28560309)
- Antipsychotic drug-induced weight gain in schizophrenia ( 31447353)
- Brain morphology (MOSTest) ( 32665545)
- Cholesterol, total ( 24097068 20686565)
- Hemoglobin ( 32888494)
- Hip circumference adjusted for BMI ( 34021172)
- LDL cholesterol ( 20686565 24097068)
- LDL cholesterol levels ( 28334899)
- LDL cholesterol levels x long total sleep time interaction (2df test) ( 31719535)
- LDL cholesterol levels x short total sleep time interaction (2df test) ( 31719535)
- Liver enzyme levels (gamma-glutamyl transferase) ( 33972514)
- Male-pattern baldness ( 28196072)
- Metabolite levels ( 23823483)
- PR interval ( 32439900)
- Red blood cell count ( 32888494)
- Refractive error ( 32231278)
- Total cholesterol levels ( 28334899)
- Urate levels ( 31578528)
- Waist-hip index ( 34021172)
- Waist-to-hip ratio adjusted for BMI ( 34021172)
|
- Alzheimer's disease (late onset) ( 30820047)
- Alzheimer's disease or fasting glucose levels (pleiotropy) ( 30805717)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Immunoglobulin A ( 20694011)
- Pulse pressure ( 30578418)
- Schizophrenia ( 29483656)
- Serum metabolite levels ( 33031748)
|